APGE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 36.10%

Insider Buying (Last 12 Months): $990,800.00

Insider Selling (Last 12 Months): $12,518,609.60

Apogee Therapeutics Insider Trading History Chart

Apogee Therapeutics Share Price & Price History

^$33.11

▲ +1.07 (3.34%)

As of 04/17/2025 05:00 PM ET

Days: 30 | 90 | 365

Apogee Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/2/2025	Carl Dambkowski	Insider	Sell	3,860	$36.22	$139,809.20	247,173
3/5/2025	Carl Dambkowski	Insider	Sell	1,590	$30.48	$48,463.20	251,033
3/5/2025	Michael Thomas Henderson	CEO	Sell	10,000	$30.15	$301,500.00	1,292,987
2/5/2025	Carl Dambkowski	Insider	Sell	3,520	$40.69	$143,228.80	252,623
2/5/2025	Michael Thomas Henderson	CEO	Sell	15,000	$40.58	$608,700.00	1,302,987
1/8/2025	Michael Thomas Henderson	CEO	Sell	15,000	$48.85	$732,750.00	1,309,487
1/2/2025	Carl Dambkowski	Insider	Sell	4,085	$46.94	$191,749.90	255,348
12/12/2024	Mark C Mckenna	Director	Buy	20,000	$49.54	$990,800.00	20,000
12/11/2024	Carl Dambkowski	Insider	Sell	4,540	$48.76	$221,370.40	258,073
12/4/2024	Carl Dambkowski	Insider	Sell	6,665	$46.07	$307,056.55	260,798
12/4/2024	Michael Thomas Henderson	CEO	Sell	15,000	$46.58	$698,700.00	1,324,487
11/6/2024	Carl Dambkowski	Insider	Sell	6,665	$59.12	$394,034.80	267,463
11/6/2024	Michael Thomas Henderson	CEO	Sell	15,000	$59.22	$888,300.00	1,339,487
10/2/2024	Carl Dambkowski	Insider	Sell	6,665	$56.26	$374,972.90	274,128
10/2/2024	Michael Thomas Henderson	CEO	Sell	40,000	$56.23	$2,249,200.00	1,354,487
9/4/2024	Carl Dambkowski	Insider	Sell	6,665	$47.56	$316,987.40	280,793
9/4/2024	Michael Thomas Henderson	CEO	Sell	40,000	$47.62	$1,904,800.00	1,394,487
8/23/2024	Jane Henderson	CFO	Sell	6,000	$48.26	$289,560.00	200,871
8/7/2024	Carl Dambkowski	Insider	Sell	7,335	$40.67	$298,314.45	287,458
8/7/2024	Michael Thomas Henderson	CEO	Sell	40,000	$40.62	$1,624,800.00	1,434,487
7/5/2024	Michael Thomas Henderson	CEO	Sell	15,000	$37.26	$558,900.00	1,474,487
7/3/2024	Carl Dambkowski	Insider	Sell	5,995	$37.60	$225,412.00	294,793
7/13/2023	Nimish P Shah	Director	Buy	1,750,000	$17.00	$29,750,000.00	1,750,000

See Full Table

SEC Filings (Institutional Ownership Changes) for Apogee Therapeutics (NASDAQ:APGE)

79.04% of Apogee Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Apogee Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/8/2025	Rhumbline Advisers	54,385	$2.03M	0.0%	+3.2%	0.121%
4/7/2025	GAMMA Investing LLC	5,417	$0.20M	0.0%	+3,560.1%	0.012%
3/18/2025	California State Teachers Retirement System	22,178	$1.01M	0.0%	+13.1%	0.049%
2/28/2025	Universal Beteiligungs und Servicegesellschaft mbH	143,952	$6.52M	0.0%	N/A	0.320%
2/19/2025	GF Fund Management CO. LTD.	945	$43K	0.0%	N/A	0.002%
2/18/2025	Neo Ivy Capital Management	38,523	$1.75M	0.4%	N/A	0.086%
2/17/2025	Voloridge Investment Management LLC	41,106	$1.86M	0.0%	-1.5%	0.091%
2/17/2025	Woodline Partners LP	1,015,608	$46.01M	0.3%	+4.0%	2.255%
2/17/2025	Soleus Capital Management L.P.	70,000	$3.17M	0.2%	N/A	0.155%
2/17/2025	Squarepoint Ops LLC	36,344	$1.65M	0.0%	+90.9%	0.081%
2/17/2025	Two Sigma Advisers LP	71,500	$3.24M	0.0%	+51.5%	0.159%
2/17/2025	Two Sigma Investments LP	266,482	$12.07M	0.0%	+33.7%	0.592%
2/17/2025	Rafferty Asset Management LLC	57,673	$2.61M	0.0%	+5.7%	0.128%
2/17/2025	Point72 Asset Management L.P.	302,735	$13.71M	0.0%	-57.2%	0.672%
2/17/2025	ProShare Advisors LLC	12,805	$0.58M	0.0%	+30.4%	0.028%
2/17/2025	Paradigm Biocapital Advisors LP	1,283,766	$58.16M	2.0%	+82.9%	2.851%
2/17/2025	Parkman Healthcare Partners LLC	85,000	$3.85M	0.5%	N/A	0.189%
2/17/2025	Nuveen Asset Management LLC	137,826	$6.24M	0.0%	+1.8%	0.306%
2/17/2025	Millennium Management LLC	130,171	$5.90M	0.0%	+44.6%	0.289%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	23,835	$1.08M	0.0%	+4.1%	0.053%
2/17/2025	Janus Henderson Group PLC	1,135,100	$51.46M	0.0%	+141.7%	2.521%
2/17/2025	Jefferies Financial Group Inc.	887,497	$40.20M	0.2%	+140.4%	1.971%
2/17/2025	Granahan Investment Management LLC	92,854	$4.21M	0.2%	+1.2%	0.206%
2/17/2025	Frontier Capital Management Co. LLC	172,711	$7.82M	0.1%	-44.5%	0.384%
2/17/2025	Family Management Corp	7,013	$0.32M	0.1%	-13.2%	0.016%
2/17/2025	D. E. Shaw & Co. Inc.	9,813	$0.45M	0.0%	-80.2%	0.022%
2/17/2025	Deutsche Bank AG	31,739	$1.44M	0.0%	+50.9%	0.070%
2/17/2025	Driehaus Capital Management LLC	2,605,310	$118.02M	1.0%	+2.8%	5.786%
2/17/2025	Cubist Systematic Strategies LLC	91,213	$4.13M	0.0%	+8.6%	0.203%
2/17/2025	Braidwell LP	1,540,362	$69.78M	2.1%	-6.3%	3.421%
2/17/2025	Bank of America Corp DE	105,540	$4.78M	0.0%	-64.8%	0.234%
2/17/2025	BNP Paribas Financial Markets	4,824	$0.22M	0.0%	N/A	0.011%
2/17/2025	Ameriprise Financial Inc.	5,710	$0.26M	0.0%	N/A	0.013%
2/17/2025	Allostery Investments LP	100,000	$4.53M	4.7%	N/A	0.222%
2/14/2025	Boxer Capital Management LLC	86,000	$3.90M	0.3%	N/A	0.191%
2/14/2025	RA Capital Management L.P.	1,569,491	$71.10M	0.9%	-20.0%	3.485%
2/14/2025	Mercer Global Advisors Inc. ADV	720,101	$32.62M	0.1%	N/A	1.599%
2/14/2025	Comerica Bank	20,540	$0.93M	0.0%	-26.8%	0.046%
2/14/2025	Schonfeld Strategic Advisors LLC	70,766	$3.21M	0.0%	N/A	0.157%
2/14/2025	Northern Trust Corp	327,292	$14.83M	0.0%	+6.8%	0.727%
2/14/2025	The Manufacturers Life Insurance Company	87,953	$3.98M	0.0%	+29.4%	0.195%
2/14/2025	Virtus ETF Advisers LLC	1,604	$73K	0.0%	-25.0%	0.004%
2/14/2025	Voya Investment Management LLC	45,960	$2.08M	0.0%	-18.7%	0.102%
2/14/2025	Adage Capital Partners GP L.L.C.	240,200	$10.88M	0.0%	N/A	0.533%
2/14/2025	Price T Rowe Associates Inc. MD	1,052,595	$47.68M	0.0%	+38.8%	2.338%
2/14/2025	Diadema Partners LP	50,620	$2.29M	1.0%	N/A	0.112%
2/14/2025	B Group Inc.	15,000	$0.68M	0.4%	N/A	0.033%
2/14/2025	Tower Research Capital LLC TRC	6,287	$0.29M	0.0%	+356.6%	0.014%
2/14/2025	MetLife Investment Management LLC	22,960	$1.04M	0.0%	+8.7%	0.051%
2/14/2025	Capital World Investors	205,100	$9.29M	0.0%	N/A	0.455%
2/13/2025	Marshall Wace LLP	75,849	$3.44M	0.0%	+1,963.9%	0.168%
2/13/2025	Affinity Asset Advisors LLC	931,728	$42.21M	5.6%	+40.3%	2.069%
2/13/2025	Jump Financial LLC	20,867	$0.95M	0.0%	N/A	0.046%
2/13/2025	XTX Topco Ltd	6,348	$0.29M	0.0%	N/A	0.014%
2/13/2025	Barclays PLC	476,760	$21.60M	0.0%	+30.6%	1.059%
2/13/2025	Optimize Financial Inc	4,473	$0.20M	0.2%	N/A	0.010%
2/13/2025	Kennedy Capital Management LLC	72,307	$3.28M	0.1%	+75.5%	0.161%
2/13/2025	Legal & General Group Plc	25,873	$1.17M	0.0%	+15.7%	0.057%
2/13/2025	Invesco Ltd.	21,256	$0.96M	0.0%	-83.9%	0.047%
2/13/2025	ADAR1 Capital Management LLC	41,274	$1.87M	0.4%	-27.8%	0.092%
2/13/2025	FMR LLC	7,499,382	$339.72M	0.0%	0.0%	16.654%
2/13/2025	Wells Fargo & Company MN	17,705	$0.80M	0.0%	-82.0%	0.039%
2/12/2025	Geode Capital Management LLC	816,113	$36.98M	0.0%	-0.9%	1.812%
2/12/2025	Franklin Resources Inc.	866,188	$39.24M	0.0%	+0.6%	1.924%
2/12/2025	Alliancebernstein L.P.	1,355,185	$61.39M	0.0%	+13.5%	3.010%
2/12/2025	Wellington Management Group LLP	4,517,363	$204.64M	0.0%	-6.2%	10.033%
2/12/2025	JPMorgan Chase & Co.	37,255	$1.69M	0.0%	+26.1%	0.083%
2/11/2025	Corebridge Financial Inc.	18,839	$0.85M	0.0%	-7.0%	0.042%
2/11/2025	Vanguard Group Inc.	2,097,597	$95.02M	0.0%	-1.4%	4.658%
2/11/2025	KLP Kapitalforvaltning AS	5,000	$0.23M	0.0%	N/A	0.011%
2/11/2025	Teacher Retirement System of Texas	6,689	$0.30M	0.0%	+38.2%	0.015%
2/11/2025	Platinum Investment Management Ltd.	95,646	$4.33M	0.3%	-11.2%	0.212%
2/11/2025	Intech Investment Management LLC	16,934	$0.77M	0.0%	+232.0%	0.038%
2/10/2025	Commonwealth Equity Services LLC	4,906	$0.22M	0.0%	N/A	0.011%
2/10/2025	Erste Asset Management GmbH	24,000	$1.10M	0.0%	N/A	0.053%
2/10/2025	Swiss National Bank	44,300	$2.01M	0.0%	+17.5%	0.098%
2/7/2025	Candriam S.C.A.	85,661	$3.88M	0.0%	-4.8%	0.190%
2/6/2025	Arizona State Retirement System	6,517	$0.30M	0.0%	+17.3%	0.014%
2/6/2025	Aigen Investment Management LP	4,767	$0.22M	0.0%	N/A	0.011%
2/6/2025	Victory Capital Management Inc.	223,062	$10.11M	0.0%	-35.6%	0.495%
2/6/2025	Charles Schwab Investment Management Inc.	277,492	$12.57M	0.0%	-1.0%	0.616%
2/4/2025	Bank of New York Mellon Corp	110,827	$5.02M	0.0%	-1.6%	0.246%
2/3/2025	Handelsbanken Fonder AB	7,500	$0.34M	0.0%	-14.8%	0.017%
1/31/2025	New York State Common Retirement Fund	12,187	$0.55M	0.0%	+8.9%	0.027%
1/31/2025	AlphaCentric Advisors LLC	5,649	$0.26M	0.3%	-33.5%	0.013%
1/30/2025	Rhumbline Advisers	52,720	$2.39M	0.0%	+3.4%	0.117%
1/24/2025	China Universal Asset Management Co. Ltd.	9,547	$0.43M	0.0%	+10.3%	0.021%
1/17/2025	SG Americas Securities LLC	9,890	$0.45M	0.0%	+22.2%	0.022%
12/26/2024	JPMorgan Chase & Co.	29,555	$1.74M	0.0%	+4.3%	0.066%
12/19/2024	Principal Financial Group Inc.	3,517	$0.21M	0.0%	-45.4%	0.008%
11/27/2024	Franklin Resources Inc.	860,989	$48.05M	0.0%	-14.4%	1.912%
11/18/2024	Teachers Retirement System of The State of Kentucky	11,644	$0.68M	0.0%	-21.4%	0.026%
11/16/2024	Geode Capital Management LLC	823,839	$48.40M	0.0%	+11.2%	1.830%
11/15/2024	Barclays PLC	365,046	$21.44M	0.0%	+369.2%	0.811%
11/15/2024	Wellington Management Group LLP	4,814,400	$282.80M	0.0%	+35.7%	10.692%
11/15/2024	Wexford Capital LP	3,922	$0.23M	0.1%	N/A	0.009%
11/15/2024	State Street Corp	1,411,639	$82.92M	0.0%	-9.6%	3.135%
11/15/2024	Point72 DIFC Ltd	19,207	$1.13M	0.0%	+14.5%	0.043%
11/15/2024	Point72 Asset Management L.P.	707,268	$41.55M	0.1%	+162.7%	1.571%
11/15/2024	Janus Henderson Group PLC	469,557	$27.59M	0.0%	+4,018.9%	1.043%

Data available starting January 2016

See Full Table

Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), asthma, chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs comprise APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. Apogee Therapeutics, Inc. was incorporated in 2022 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $33.11

$31.60

$33.38

50 Day Range

MA: $35.17

$28.79

$40.84

52 Week Range

Now: $33.11

$26.20

$63.50

Volume

347,971 shs

Average Volume

507,411 shs

Market Capitalization

$1.49 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.72

Who are the company insiders with the largest holdings of Apogee Therapeutics?: Apogee Therapeutics' top insider shareholders include:
Nimish P Shah (Director)
Michael Thomas Henderson (CEO)
Carl Dambkowski (Insider)
Jane Henderson (CFO)
Mark C Mckenna (Director)
Learn More about top insider investors at Apogee Therapeutics.
Who are the major institutional investors of Apogee Therapeutics?: Apogee Therapeutics' top institutional shareholders include:
Rhumbline Advisers — 0.12%
GAMMA Investing LLC — 0.01%
Learn More about top institutional investors of Apogee Therapeutics stock.
Which institutional investors are buying Apogee Therapeutics stock?: In the last quarter, APGE stock was bought by institutional investors including:
GAMMA Investing LLC
Rhumbline Advisers
In the last year, these company insiders have bought Apogee Therapeutics stock:
Nimish P Shah (Director)
Michael Thomas Henderson (CEO)
Learn More investors buying Apogee Therapeutics stock.